Molecular characterization of Novel ATM fusions in chronic lymphocytic leukemia and T-cell prolymphocytic leukemia

Keyphrases

• Molecular Characterization 100%
• Chronic Lymphocytic Leukemia Cells 100%
• T-cell Prolymphocytic Leukemia 100%
• Chronic Lymphocytic Leukemia 80%
• Mate-pair Sequencing 60%
• ATM mutation 40%
• Hematological Malignancies 20%
• Protein Expression 20%
• Loss Function 20%
• Leukemia Patients 20%
• High-throughput Technologies 20%
• Next-generation Sequencing 20%
• Aberrations 20%
• Sequencing Technology 20%
• Mutation Analysis 20%
• Complex Karyotype 20%
• Fluorescence in Situ Hybridization 20%
• Lymphoid Neoplasms 20%
• Pathogenic Genes 20%
• Gene Fusion 20%
• Complex Chromosomal Rearrangement 20%
• 11q Deletion 20%
• Laboratory Technology 20%
• Conventional Karyotype 20%
• ATM Deletion 20%
• USP28 20%

Medicine and Dentistry

• Leukemia Cell 100%
• B-Cell Chronic Lymphocytic Leukemia 100%
• Prolymphocytic Leukemia 100%
• T Cell 100%
• Karyotype 40%
• Neoplasm 20%
• Protein Expression 20%
• Fluorescence in Situ Hybridization 20%
• Hematologic Malignancy 20%
• Next Generation Sequencing 20%
• Gene Fusion 20%

Biochemistry, Genetics and Molecular Biology

• Karyotype 100%
• T Cell 100%
• Chromosomal Rearrangement 50%
• Next Generation Sequencing 50%
• Protein Expression 50%
• Fluorescence in Situ Hybridization 50%
• Gene Fusion 50%